Coeptis Therapeutics Inc.

NASDAQ: COEP · Real-Time Price · USD
13.96
2.48 (21.60%)
At close: Aug 15, 2025, 3:59 PM
13.81
-1.11%
After-hours: Aug 15, 2025, 06:35 PM EDT

Coeptis Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
532.88K 1.47M 3.79M 2.18M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
5.69M n/a n/a n/a
Other Long-Term Assets
1.56M 158.33K 3.9M 4.55M
Receivables
n/a 38.98K 8.07K n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
1.05M 1.75M 3.94M 2.18M
Property-Plant & Equipment
59.78K 108.88K 71.46K 31.85K
Goodwill & Intangibles
541.88K 2.55M n/a n/a
Total Long-Term Assets
7.86M 2.82M 3.97M 4.59M
Total Assets
8.91M 4.57M 7.92M 6.77M
Account Payables
1.27M 1.42M 99.02K 134.09K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
1.19M 975K 1.5M 2.42M
Other Current Liabilities
1.28M n/a 350K n/a
Total Current Liabilities
4.51M 2.99M 1.82M 2.76M
Long-Term Debt
150K 150K 150K 1.65M
Other Long-Term Liabilities
359.25K 557.25K 1.13M n/a
Total Long-Term Liabilities
528.13K 768.43K 1.29M 1.65M
Total Liabilities
5.04M 3.76M 3.11M 4.41M
Total Debt
1.4M 1.22M 1.71M 4.08M
Common Stock
212.00 3.53K 1.96K 3.55K
Retained Earnings
-98.23M -87.36M -65.74M -27.55M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
3.19M 813.96K 4.8M 2.35M
Total Investments
5.69M 3.5M n/a n/a